Trial Profile
A phase 2 dose exploratory study of K-877
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2019
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary) ; Fenofibrate
- Indications Dyslipidaemias; Hypertriglyceridaemia; Low HDL cholesterol
- Focus Therapeutic Use
- Sponsors Kowa
- 18 Nov 2019 Results of lipoprotein subclass measured by GP-HPLC and NMR by using dat from this study presented at the American Heart Association Scientific Sessions 2019.
- 20 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.